Letter to the editor in reference to article titled: Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes

被引：0
|
作者：
Pokharna, H. [1 ]
Kanna, B. [1 ]
机构：
[1] Cornell Univ, Weill Med Coll, Lincoln Med & Mental Hlth Ctr, Bronx, NY USA
来源：
DIABETES OBESITY & METABOLISM | 2007年 / 9卷 / 06期
关键词：
D O I：
10.1111/j.1463-1326.2007.00721.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：914 / 914
页数：1
相关论文
共 50 条
  • [1] Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes
    Rosenstock, J.
    Rood, J.
    Cobitz, A.
    Biswas, N.
    Chou, H.
    Garber, A.
    [J]. DIABETES OBESITY & METABOLISM, 2006, 8 (06): : 650 - 660
  • [2] Response to Pokharna and Kanna: Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes
    Garber, A.
    [J]. DIABETES OBESITY & METABOLISM, 2008, 10 (05): : 436 - 437
  • [3] The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus
    Reasner, C.
    Olansky, L.
    Seck, T. L.
    Williams-Herman, D. E.
    Chen, M.
    Terranella, L.
    Johnson-Levonas, A. O.
    Kaufman, K. D.
    Goldstein, B. J.
    [J]. DIABETES OBESITY & METABOLISM, 2011, 13 (07): : 644 - 652
  • [4] Rosiglitazone and metformin fixed-dose combination provides superior glycaemic control compared to metformin and rosiglitazone monotherapies, and was well tolerated in drug-naive type 2 diabetes patients
    Chou, H
    Rood, J
    Biswas, N
    Strow, L
    Krebs, J
    Parikh, S
    Huang, C
    Cobitz, AR
    [J]. DIABETOLOGIA, 2005, 48 : A278 - A279
  • [5] Comparison of fixed-dose rosiglitazone/metformin combination therapy with sulphonylurea plus metformin in overweight individuals with type 2 diabetes inadequately controlled on metformin alone
    Hamann, A.
    Puig, J. Garcia
    Paul, G.
    Donaldson, J.
    Stewart, M.
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2008, 116 (01) : 6 - 13
  • [6] Effects of Rosiglitazone/Metformin Fixed-Dose Combination Therapy and Metformin Monotherapy on Serum Vaspin, Adiponectin and IL-6 Levels in Drug-Naive Patients with Type 2 Diabetes
    Kadoglou, N. P. E.
    Kapelouzou, A.
    Tsanikidis, H.
    Vitta, I.
    Liapis, C. D.
    Sailer, N.
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2011, 119 (02) : 63 - 68
  • [7] Effects of initial use of half-maximal dose rosiglitazone-metformin combination therapy, compared with maximum dose rosiglitazone or metformin, on glucose metabolism in type 2 diabetes mellitus
    Choe, Charles
    Christiansen, Louis
    Edelman, Steven
    Mudaliar, Sunder
    Henry, Robert R.
    [J]. DIABETES, 2006, 55 : A107 - A107
  • [8] Improvement in glycaemic control with rosiglitazone/metformin fixed-dose combination therapy in patients with type 2 diabetes with very poor glycaemic control
    Rosenstock, J.
    Rood, J.
    Cobitz, A.
    Huang, C.
    Garber, A.
    [J]. DIABETES OBESITY & METABOLISM, 2006, 8 (06): : 643 - 649
  • [9] Initial treatment with fixed-dose combination rosiglitazone/glimepiride in patients with previously untreated type 2 diabetes
    Chou, H. S.
    Palmer, J. P.
    Jones, A. R.
    Waterhouse, B.
    Ferreira-Cornwell, C.
    Krebs, J.
    Goldstein, B. J.
    [J]. DIABETES OBESITY & METABOLISM, 2008, 10 (08): : 626 - 637
  • [10] Rosiglitazone plus metformin: combination therapy for type 2 diabetes
    Del Prato, S
    Volpe, L
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (06) : 1411 - 1422
12345